Regular biography
Dr. Robert Appleby is a distinguished physicist with a focus on accelerator physics, beam dynamics, and applications in high-energy physics and medical technologies. He is a leading expert in the design and operation of particle accelerators, particularly in the context of the Large Hadron Collider (LHC) and its upgrades. His work has been instrumental in advancing the UK's participation in the LHC and in developing new technologies for proton therapy, a form of cancer treatment that uses high-energy protons to target tumors with precision. Dr. Appleby has also contributed to the development of mass spectrometry techniques for characterizing virus-based drug products, highlighting his interdisciplinary approach to scientific research. He is currently a Principal Investigator on several projects, including the HL-LHC-UK phase 2 and the HTPCPPT initiative, which aims to advance proton therapy research. His career has been marked by significant contributions to both fundamental physics and applied technologies, with a strong emphasis on collaboration and innovation.